LI-RADS v2018评估非肝细胞癌的原发性肝癌:LI-RADS目标人群与无LI-RADS定义的HCC危险因素患者的比较
回顾性纳入2007至2017年两家肝移植中心经病理证实的非肝细胞癌原发性肝癌265个病灶,按LI-RADS v2018分为HCC高危组与低危组,由两名盲法独立阅片者分类。高危组病灶更易出现非环状动脉期高强化和非周边「廓清」,更少出现周边「廓清」和延迟期中央强化,且被误分类为可能或肯定HCC的比例更高。
要点
- HCC高危患者中的非HCC原发性肝癌更易出现非环状动脉期高强化和非周边「廓清」等LI-RADS主要征象。
- HCC高危患者中的非HCC原发性肝癌更少出现周边「廓清」和延迟期中央强化等LR-M征象。
- 高危组非HCC原发性肝癌被误分类为可能或肯定HCC的比例显著高于低危组。
核心结论
- 在LI-RADS目标人群中,非HCC原发性肝癌在CT和MRI上比无LI-RADS定义的HCC危险因素患者更易模仿HCC。
- LI-RADS定义的HCC危险因素的存在似乎会改变非HCC原发性肝癌的影像表现,导致主要征象出现频率更高、LR-M征象出现频率更低。
研究设计与样本
- 回顾性研究,纳入2007至2017年两家肝移植中心所有经病理证实的非HCC原发性肝癌,均行肝脏方案CT或MRI检查。
- 按LI-RADS v2018标准将患者定义为HCC高危(RF+)或非高危(RF-)。
- 两名独立盲法阅片者(R1、R2)使用LI-RADS v2018对265个病灶进行分类。
- 采用逻辑回归评估RF+与RF-患者间影像特征频率差异,采用Fisher精确检验评估误分类率差异。
关键影像表现/征象
- 非HCC原发性肝癌在RF+患者中较RF-患者更易出现非环状动脉期高强化(R1:OR=2.94;R2:OR=7.09)。
- 非HCC原发性肝癌在RF+患者中较RF-患者更易出现非周边「廓清」(R1:OR=3.65;R2:OR=7.69)。
- 非HCC原发性肝癌在RF+患者中较RF-患者更少出现周边「廓清」(R1:OR=0.30;R2:OR=0.10)。
- 非HCC原发性肝癌在RF+患者中较RF-患者更少出现延迟期中央强化(R1:OR=0.18;R2:OR=0.25)。
诊断标准与关键数值
- 采用LI-RADS v2018分类标准,误分类定义为分类为可能或肯定HCC。
- RF+组非HCC原发性肝癌误分类为可能或肯定HCC的比例:R1为23.3%,R2为11.0%。
- RF-组非HCC原发性肝癌误分类为可能或肯定HCC的比例:R1为3.6%,R2为2.6%。
- RF+组与RF-组误分类率比较:R1 p<0.001,R2 p=0.009。
临床应用与阅片要点
- 在LI-RADS目标人群中阅片时,非HCC原发性肝癌更易表现为非环状动脉期高强化和非周边「廓清」,需注意与HCC鉴别。
- RF+患者中非HCC原发性肝癌出现LR-M征象(周边「廓清」、延迟期中央强化)的频率更低,可能增加误分类为HCC的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether the LI-RADS imaging features of primary liver carcinomas (PLCs) other than hepatocellular carcinoma (non-HCC PLCs) differ between patients considered high risk (RF+) versus not high risk (RF-) for HCC and to compare rates of miscategorization as probable or definite HCC between the RF+ and RF- populations.
METHODS: This retrospective study included all pathology-proven non-HCC PLCs imaged with liver-protocol CT or MRI from 2007 to 2017 at two liver transplant centers. Patients were defined per LI-RADS v2018 criteria as RF+ or RF-. Two independent, blinded readers (R1, R2) categorized 265 lesions using LI-RADS v2018. Logistic regression was utilized to assess for differences in imaging feature frequencies between RF+ and RF- patients. Fisher's exact test was used to assess for differences in miscategorization rates.
RESULTS: Non-HCC PLCs were significantly more likely to exhibit nonrim arterial phase hyperenhancement (R1: OR = 2.94; R2: OR = 7.09) and nonperipheral "washout" (R1: OR = 3.65; R2: OR = 7.69) but significantly less likely to exhibit peripheral "washout" (R1: OR = 0.30; R2: OR = 0.10) and delayed central enhancement (R1: OR = 0.18; R2: OR = 0.25) in RF+ patients relative to RF- patients. Consequently, non-HCC PLCs were more often miscategorized as probable or definite HCC in RF+ versus RF- patients (R1: 23.3% vs. 3.6%, p < 0.001; R2: 11.0% vs. 2.6%, p = 0.009).
CONCLUSIONS: Non-HCC PLCs are more likely to mimic HCCs on CT and MRI in the LI-RADS target population than in patients without LI-RADS-defined HCC risk factors.
KEY POINTS: • The presence of LI-RADS-defined risk factors for HCC tends to alter the imaging appearances of non-HCC PLCs, resulting in higher frequencies of major features and lower frequencies of LR-M features. • Non-HCC PLCs are more likely to be miscategorized as probable or definite HCC in the LI-RADS target population than in patients without LI-RADS-defined HCC risk factors.
引用
- Fraum TJ, Cannella R, Ludwig DR, et al. Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors. Eur Radiol. 2019. PMID: 31654212. doi:10.1007/s00330-019-06448-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。